Prognostic potential of Akt, pAkt(Ser473) and pAkt(Thr308) immunoreactivity in relation to HPV prevalence in head and neck squamous cell carcinoma patients
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 229, 153684
Abstract
No abstract availableKeywords
Funding Information
- Narodowym Centrum Nauki
- National Science Centre Poland (2016/21/N/NZ5/00227)
This publication has 32 references indexed in Scilit:
- The HPV16 E6 Oncoprotein Causes Prolonged Receptor Protein Tyrosine Kinase Signaling and Enhances Internalization of Phosphorylated Receptor SpeciesPLOS Pathogens, 2013
- Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patientsBMC Clinical Pathology, 2013
- mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous CarcinomasClinical Cancer Research, 2012
- PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patientsJournal of Cancer Research and Clinical Oncology, 2011
- Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period AnalysisThe Oncologist, 2010
- Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory proteinOncogene, 2009
- Radiation Response in Two HPV-Infected Head-and-Neck Cancer Cell Lines in Comparison to a Non–HPV-Infected Cell Line and Relationship to Signaling Through AKTInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Expression of Protein Tyrosine Kinases in Head and Neck Squamous Cell CarcinomasAmerican Journal of Clinical Pathology, 2005
- Activated Akt expression in breast cancer: Correlation with p53, Hdm2 and patient outcomeEuropean Journal of Cancer, 2005
- Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinomaCancer, 2002